Clinic
Ann Arbor Urgent Care, P.C
Ann Arbor Urgent Care, P.C was paid $1.46M by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoANN ARBOR URGENT CARE, P.C
ANN ARBOR, MI 48104
ANN ARBOR, MI 48104
33aNPI1265507669assigned 11/21/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.46M
24GClaims43,397
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#47 of 239
Median peer was paid$346K
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,883 | $222K | |
| 2019 | 5,977 | $205K | |
| 2020 | 9,113 | $283K | |
| 2021 | 9,730 | $314K | |
| 2022 | 5,989 | $206K | |
| 2023 | 3,501 | $137K | |
| 2024incomplete | 2,204 | $98K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 6,952 | 6,061 | $455K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 21% | 4,823 | 4,807 | $308K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 4,758 | 4,338 | $240K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 5,440 | 4,919 | $167K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.2% | 2,567 | 2,521 | $62K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.8% | 1,583 | 1,301 | $55K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.7% | 1,211 | 1,211 | $54K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 2,875 | 2,819 | $35K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 2,493 | 2,259 | $26K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 1,051 | 973 | $19K |
| 99000 | <1% | 2,441 | 2,259 | $11K | |
| 81025 | <1% | 854 | 832 | $5K |
21 more codes
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 974 | $5K |
| 81002 | <1% | 1,836 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 235 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 419 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 62 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 158 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,084 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $1K |
| 94060 | <1% | 43 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 743 | $962.46 |
| 36415 | Collection of venous blood by venipuncture | <1% | 462 | $721.85 |
| 86308 | <1% | 110 | $440.10 | |
| 69210 | <1% | 15 | $413.10 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 19 | $212.52 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $5.98 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 73 | $0.20 |
| 36000 | 0% | 14 | $0.00 | |
| 3074F | 0% | 25 | $0.00 | |
| 3078F | 0% | 19 | $0.00 | |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | 0% | 15 | $0.00 |
| 99051 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJUSSEINALL, ALAA (OWNER)